Bioasis Technologies Inc.
Bioasis Technologies Inc. (BIOAF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOAF · as of Jun 9, 2026
Key Statistics
Explore Bioasis Technologies Inc. Data
bioaf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bioaf competitorsBIOAF
BLFE
BNYN
EMYSF
GBLX
GSTCStock Performance
Full HistoryAbout Bioasis Technologies Inc.
Bioasis Technologies Inc. is a developing biopharmaceutical enterprise dedicated to the discovery and advancement of treatments and diagnostic tools for various neurological conditions. Central to its…
what is bioasis technologies inc. · bioaf stock overview · bioasis technologies inc. company profile · who is bioasis technologies inc. ceo · bioaf OTC · bioasis technologies inc. headquarters · bioasis technologies inc. business segments
About Stock Overview & Key Data
Bioasis Technologies Inc. (BIOAF) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 31, 2010. As of the latest trading session, BIOAF stock price is $0.00, with a market capitalization of $7,941. The stock has returned -50.00% over the past 12 months and -50.00% year-to-date.
In fiscal year 2022, Bioasis Technologies Inc. reported revenue of $37725.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bioasis Technologies Inc. (BIOAF) stock price is $0.00. The stock is traded on OTC under the ticker symbol BIOAF. The 52-week range is $0.00 – $0.00.